Articles
-
1 week ago |
mddionline.com | Omar Ford
MedTech Europe is calling on European policymakers to exempt medical technologies from any trade tariffs or export restrictions. The measure comes in response to the European Commission closing its public consultation on a list of EU countermeasures that could be applied to both imports from and exports to the United States, paving the way for a second package of retaliatory measures.
-
1 week ago |
mddionline.com | Omar Ford
At a GlanceBorn from Shifamed's innovation hub, Enlil delivers enterprise-grade compliance tools in a scalable platform. Enlil's solution addresses pain points by replacing fragmented spreadsheets with paper records with a centralized system. Enlil was founded to solve a critical challenge for medical device innovators: efficiently navigating regulated product development without being hindered by disconnected systems, manual processes, or enterprise-level costs.
-
1 week ago |
mddionline.com | Omar Ford
The rumored deal comes a few months after the Waltham, MA-based company said it would acquire Solventum’s Purification & Filtration unit in a deal valued at $4.1 billion. Thermo Fisher Scientific is putting up part of its diagnostics unit for sale, in the latest installment of larger medtech companies shedding low-performing units, according to a report from the Financial Times.
-
1 week ago |
mddionline.com | Omar Ford
Medtronic has issued a voluntary recall related to its Newport HT70 and HT70 Plus ventilators and certain related Newport service parts. FDA has designated the voluntary action by the Dublin-based company as a Class I recall. With this recall, Medtronic is advising the discontinuation of clinical use of the affected devices. Investigation into customer complaints identified two separate capacitors on one of the ventilator’s controllers, Printed Circuit Board Assembly (PCBA).
-
2 weeks ago |
mddionline.com | Omar Ford |Bioworld Medtech
The diabetes management sector has emerged as one of medtech's fastest-growing segments, undergoing significant transformation compared to previous years. MD+DI has identified several pivotal partnerships that have revolutionized diabetes technology and care delivery. Diabetes tech is one of the fastest-growing segments in the medical device industry.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 230
- Tweets
- 1K
- DMs Open
- No
Witnessed @OmarKhateeb delivering a powerful keynote at #MDMEast! His talk "The Third Wave: The Future of Big Tech and Medtech" made one thing clear: "This is not about what's coming or a prediction, it's already here." The future of healthcare is now! @MDDIonline #MedTech https://t.co/jAOprsMHK0
From #MDMEast: @NEBiomedical's President Timmothy Looney on manufacturer involvement: "They should be in the brainstorming in the beginning because ultimately they are going to be the ones to make the [device]." @MDDIonline #MedicalDevice #Manufacturing https://t.co/fqSIAU8Yuc
Just in from #MDMEast: @BaxterHealthcare's AK Karan kicks off with a powerful keynote: "Today automation isn't simple anymore. It's very complex. Today, we can see that automation machines now require a highly-skilled workforce." @MDDIonline #MedTech #Manufacturing #Automation https://t.co/L8E3yXNUfX